{"id":789765,"date":"2023-10-11T18:00:53","date_gmt":"2023-10-11T22:00:53","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/royalty-pharma-to-announce-third-quarter-2023-financial-results-on-november-8-2023\/"},"modified":"2023-10-11T18:00:53","modified_gmt":"2023-10-11T22:00:53","slug":"royalty-pharma-to-announce-third-quarter-2023-financial-results-on-november-8-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/royalty-pharma-to-announce-third-quarter-2023-financial-results-on-november-8-2023\/","title":{"rendered":"Royalty Pharma To Announce Third Quarter 2023 Financial Results On November 8, 2023"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">NEW YORK, Oct.  11, 2023  (GLOBE NEWSWIRE) &#8212; Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its third quarter 2023 financial results on Wednesday, November 8, 2023 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 a.m. Eastern Time that day.<\/p>\n<p>\n        <strong>Conference Call Information<\/strong>\n      <\/p>\n<p>Please visit the \u201cInvestors\u201d page of the company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DE1Dg74f4rvIs1_qexAh3O6MyR9BcqI2mJ8maZsP0kyO2ghvymCCFo0ABYwTs_UJMe0xOsoZvqrgyvv8H1nnImX_Chf0J2QKfB9to9gON_rVWdg6dko8tKukpHry21SiepVHUTpYvjehLbHsTC7dra8_H3lxtS4TSabc64xod95rDEeiCuwA9DiNspd_wNCAhF2MllOYTkI0OMDwomORPw==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.royaltypharma.com\/investors\/news-and-events\/events<\/a> to obtain conference call information and to view the live webcast. A replay of the conference call and webcast will be archived on the company&#8217;s website for at least 30 days.<\/p>\n<p>\n        <strong>About Royalty Pharma<\/strong>\n      <\/p>\n<p>Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry\u2019s leading therapies. Royalty Pharma funds innovation in the biopharmaceutical industry both directly and indirectly &#8211; directly when it partners with companies to co-fund late-stage clinical trials and new product launches in exchange for future royalties, and indirectly when it acquires existing royalties from the original innovators. Royalty Pharma\u2019s current portfolio includes royalties on more than 35 commercial products, including Vertex\u2019s Trikafta, Kalydeco, Orkambi and Symdeko, Biogen\u2019s Tysabri, AbbVie and Johnson &amp; Johnson\u2019s Imbruvica, Astellas and Pfizer\u2019s Xtandi, GSK\u2019s Trelegy, Novartis\u2019 Promacta, Pfizer\u2019s Nurtec ODT, Johnson &amp; Johnson\u2019s Tremfya, Roche\u2019s Evrysdi, Gilead\u2019s Trodelvy, and 11 development-stage product candidates. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Q_k4H3c9bZUqBr5L37C6ZiPwgnq687WS_aM-DQa1mMR2afg7Wud-PV_zBLCUtPOCzPsi1-ci4UDMv6iLE9FcD1HRAzo2t465txe1daZEwS0=\" rel=\"nofollow noopener\" target=\"_blank\">www.royaltypharma.com<\/a>.<\/p>\n<p>\n        <strong>Royalty Pharma Investor Relations and Communications<\/strong>\n      <\/p>\n<p>+1 (212) 883-6637<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NNftAXILutrNyYR7hijozPE_RfsfVHqUJMZO9K_cL9xnVjZLO_A-Ot77RSUoECxEXG_vynti6QzHwH9bUwJZDj2Kytq5eMUYg0boYhczqW4=\" rel=\"nofollow noopener\" target=\"_blank\">ir@royaltypharma.com<\/a><\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0Nzc2NyM1ODY4Nzg3IzUwMDEwNTI2NA==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MjEzNTkwYjEtN2MyNy00YTU2LWI1MTQtMjM0ZTVlZjM3YjRkLTUwMDEwNTI2NA==\/tiny\/Royalty-Pharma-plc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Oct. 11, 2023 (GLOBE NEWSWIRE) &#8212; Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its third quarter 2023 financial results on Wednesday, November 8, 2023 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 a.m. Eastern Time that day. Conference Call Information Please visit the \u201cInvestors\u201d page of the company\u2019s website at https:\/\/www.royaltypharma.com\/investors\/news-and-events\/events to obtain conference call information and to view the live webcast. A replay of the conference call and webcast will be archived on the company&#8217;s website for at least 30 days. About Royalty Pharma Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/royalty-pharma-to-announce-third-quarter-2023-financial-results-on-november-8-2023\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Royalty Pharma To Announce Third Quarter 2023 Financial Results On November 8, 2023&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-789765","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Royalty Pharma To Announce Third Quarter 2023 Financial Results On November 8, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/royalty-pharma-to-announce-third-quarter-2023-financial-results-on-november-8-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Royalty Pharma To Announce Third Quarter 2023 Financial Results On November 8, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Oct. 11, 2023 (GLOBE NEWSWIRE) &#8212; Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its third quarter 2023 financial results on Wednesday, November 8, 2023 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 a.m. Eastern Time that day. Conference Call Information Please visit the \u201cInvestors\u201d page of the company\u2019s website at https:\/\/www.royaltypharma.com\/investors\/news-and-events\/events to obtain conference call information and to view the live webcast. A replay of the conference call and webcast will be archived on the company&#8217;s website for at least 30 days. About Royalty Pharma Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across &hellip; Continue reading &quot;Royalty Pharma To Announce Third Quarter 2023 Financial Results On November 8, 2023&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/royalty-pharma-to-announce-third-quarter-2023-financial-results-on-november-8-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-11T22:00:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0Nzc2NyM1ODY4Nzg3IzUwMDEwNTI2NA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/royalty-pharma-to-announce-third-quarter-2023-financial-results-on-november-8-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/royalty-pharma-to-announce-third-quarter-2023-financial-results-on-november-8-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Royalty Pharma To Announce Third Quarter 2023 Financial Results On November 8, 2023\",\"datePublished\":\"2023-10-11T22:00:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/royalty-pharma-to-announce-third-quarter-2023-financial-results-on-november-8-2023\\\/\"},\"wordCount\":302,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/royalty-pharma-to-announce-third-quarter-2023-financial-results-on-november-8-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODk0Nzc2NyM1ODY4Nzg3IzUwMDEwNTI2NA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/royalty-pharma-to-announce-third-quarter-2023-financial-results-on-november-8-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/royalty-pharma-to-announce-third-quarter-2023-financial-results-on-november-8-2023\\\/\",\"name\":\"Royalty Pharma To Announce Third Quarter 2023 Financial Results On November 8, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/royalty-pharma-to-announce-third-quarter-2023-financial-results-on-november-8-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/royalty-pharma-to-announce-third-quarter-2023-financial-results-on-november-8-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODk0Nzc2NyM1ODY4Nzg3IzUwMDEwNTI2NA==\",\"datePublished\":\"2023-10-11T22:00:53+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/royalty-pharma-to-announce-third-quarter-2023-financial-results-on-november-8-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/royalty-pharma-to-announce-third-quarter-2023-financial-results-on-november-8-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/royalty-pharma-to-announce-third-quarter-2023-financial-results-on-november-8-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODk0Nzc2NyM1ODY4Nzg3IzUwMDEwNTI2NA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODk0Nzc2NyM1ODY4Nzg3IzUwMDEwNTI2NA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/royalty-pharma-to-announce-third-quarter-2023-financial-results-on-november-8-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Royalty Pharma To Announce Third Quarter 2023 Financial Results On November 8, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Royalty Pharma To Announce Third Quarter 2023 Financial Results On November 8, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/royalty-pharma-to-announce-third-quarter-2023-financial-results-on-november-8-2023\/","og_locale":"en_US","og_type":"article","og_title":"Royalty Pharma To Announce Third Quarter 2023 Financial Results On November 8, 2023 - Market Newsdesk","og_description":"NEW YORK, Oct. 11, 2023 (GLOBE NEWSWIRE) &#8212; Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its third quarter 2023 financial results on Wednesday, November 8, 2023 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 a.m. Eastern Time that day. Conference Call Information Please visit the \u201cInvestors\u201d page of the company\u2019s website at https:\/\/www.royaltypharma.com\/investors\/news-and-events\/events to obtain conference call information and to view the live webcast. A replay of the conference call and webcast will be archived on the company&#8217;s website for at least 30 days. About Royalty Pharma Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across &hellip; Continue reading \"Royalty Pharma To Announce Third Quarter 2023 Financial Results On November 8, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/royalty-pharma-to-announce-third-quarter-2023-financial-results-on-november-8-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-10-11T22:00:53+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0Nzc2NyM1ODY4Nzg3IzUwMDEwNTI2NA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/royalty-pharma-to-announce-third-quarter-2023-financial-results-on-november-8-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/royalty-pharma-to-announce-third-quarter-2023-financial-results-on-november-8-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Royalty Pharma To Announce Third Quarter 2023 Financial Results On November 8, 2023","datePublished":"2023-10-11T22:00:53+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/royalty-pharma-to-announce-third-quarter-2023-financial-results-on-november-8-2023\/"},"wordCount":302,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/royalty-pharma-to-announce-third-quarter-2023-financial-results-on-november-8-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0Nzc2NyM1ODY4Nzg3IzUwMDEwNTI2NA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/royalty-pharma-to-announce-third-quarter-2023-financial-results-on-november-8-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/royalty-pharma-to-announce-third-quarter-2023-financial-results-on-november-8-2023\/","name":"Royalty Pharma To Announce Third Quarter 2023 Financial Results On November 8, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/royalty-pharma-to-announce-third-quarter-2023-financial-results-on-november-8-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/royalty-pharma-to-announce-third-quarter-2023-financial-results-on-november-8-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0Nzc2NyM1ODY4Nzg3IzUwMDEwNTI2NA==","datePublished":"2023-10-11T22:00:53+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/royalty-pharma-to-announce-third-quarter-2023-financial-results-on-november-8-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/royalty-pharma-to-announce-third-quarter-2023-financial-results-on-november-8-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/royalty-pharma-to-announce-third-quarter-2023-financial-results-on-november-8-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0Nzc2NyM1ODY4Nzg3IzUwMDEwNTI2NA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0Nzc2NyM1ODY4Nzg3IzUwMDEwNTI2NA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/royalty-pharma-to-announce-third-quarter-2023-financial-results-on-november-8-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Royalty Pharma To Announce Third Quarter 2023 Financial Results On November 8, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/789765","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=789765"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/789765\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=789765"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=789765"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=789765"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}